Target
Tyrosine-protein kinase JAK1 [850-1154]
Ligand
BDBM103733
Substrate
n/a
Meas. Tech.
JAK1 Inhibition Assay
IC50
504±n/a nM
Citation
 Menet, CJSmits, KK Compound useful for the treatment of degenerative and inflammatory diseases US Patent  US11000528 Publication Date 5/11/2021 
Target
Name:
Tyrosine-protein kinase JAK1 [850-1154]
Synonyms:
JAK1 | JAK1A | JAK1B | JAK1_HUMAN | Tyrosine-protein kinase JAK1 (850-1154)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
34949.64
Organism:
n/a
Description:
aa 850-1154
Residue:
305
Sequence:
EQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK
 
Inhibitor
Name:
BDBM103733
Synonyms:
US10206907, Compound 139 | US11000528, Cpd # 7 | US8563545, 7
Type:
Small organic molecule
Emp. Form.:
C22H25N5O
Mol. Mass.:
375.4668
SMILES:
O=C(Nc1nc2cccc(-c3ccc(CN4CCCCC4)cc3)n2n1)C1CC1
Structure:
Search PDB for entries with ligand similarity: